Terpos, E., Ntanasis-Stathopoulos, I., Papassotiriou, G., Kastritis, E., Margeli, A., Kanellias, N., . . . Dimopoulos, M. A. (2020). Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction. J Clin Med.
Styl ChicagoTerpos, Evangelos, et al. "Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients With Multiple Myeloma Treated With Bortezomib-Based Induction." J Clin Med 2020.
Citace podle MLATerpos, Evangelos, et al. "Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients With Multiple Myeloma Treated With Bortezomib-Based Induction." J Clin Med 2020.